Cargando…
Atractylenolide-1 Targets FLT3 to Regulate PI3K/AKT/HIF1-α Pathway to Inhibit Osteogenic Differentiation of Human Valve Interstitial Cells
Atractylenolide-1 (AT-1), a natural active ingredient extracted from Atractylodes macrocephala, was reported to have good anti-fibrotic and anti-inflammatory effects. Osteogenic changes induced by the inflammation of valve interstitial cells (VICs) play a role in the development of calcified aortic...
Autores principales: | Wang, Jie, Zhang, Penghua, Zhang, Jing, Ma, Zhaohui, Tian, Xingqin, Liu, Yan, Lv, Guanghui, Qu, Linghang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097085/ https://www.ncbi.nlm.nih.gov/pubmed/35571096 http://dx.doi.org/10.3389/fphar.2022.899775 |
Ejemplares similares
-
High fructose induced osteogenic differentiation of human valve interstitial cells via activating PI3K/AKT/mitochondria signaling
por: Chang, Hsiao-Huang, et al.
Publicado: (2022) -
PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia
por: Zhang, Zhen, et al.
Publicado: (2018) -
Atractylenolide III ameliorated reflux esophagitis via PI3K/AKT/NF-κB/iNOS pathway in rats
por: Si, Xianzhe, et al.
Publicado: (2023) -
Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative Stress-Mediated PI3K/AKT/mTOR Pathway
por: Wang, Mingqing, et al.
Publicado: (2019) -
Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism
por: Wang, Yan, et al.
Publicado: (2023)